Can immunostimulatory agents enhance the abscopal effect of radiotherapy?

No abstract is available for this paper.

• Publication year

  2016

• Venue

  European Journal of Cancer

• Publication date

  2016-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ejca.2016.03.067PMID 27200491
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?

  2016cited by this paper
• Ionizing radiation modulates human macrophages towards a pro-inflammatory phenotype preserving their pro-invasive and pro-angiogenic capacities

  2016cited by this paper
• Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper.

  2016cited by this paper
• Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.

  2015cited by this paper
• Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.

  2015cited by this paper
• Radiothérapie et immunomodulation : mise au point sur les données expérimentales

  2015cited by this paper
• Targeting the inhibitory receptor CTLA-4 on T cells increased abscopal effects in murine mesothelioma model

  2015cited by this paper
• Pembrolizumab versus Ipilimumab in Advanced Melanoma.

  2015cited by this paper
• Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial.

  2015cited by this paper
• Synergy of Radiotherapy and a Cancer Vaccine for the Treatment of HPV-Associated Head and Neck Cancer

  2015cited by this paper
• Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial.

  2015cited by this paper
• Radiation and Dual Checkpoint Blockade Activates Non-Redundant Immune Mechanisms in Cancer

  2015cited by this paper
• TH2-Polarized CD4+ T Cells and Macrophages Limit Efficacy of Radiotherapy

  2015cited by this paper
• Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.

  2015cited by this paper
• Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.

  2015cited by this paper
• A systematic evaluation of abscopal responses following radiotherapy in patients with metastatic melanoma treated with ipilimumab

  2015cited by this paper
• Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy.

  2015cited by this paper
• [Radiation therapy and immunomodulation: Focus on experimental data].

  2015cited by this paper
• The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant.

  2015cited by this paper
• PD-1 Restrains Radiotherapy-Induced Abscopal Effect

  2015cited by this paper
• TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity.

  2015cited by this paper
• Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial.

  2014cited by this paper
• Macrophage inflammatory protein derivative ECI301 enhances the alarmin-associated abscopal benefits of tumor radiotherapy.

  2014cited by this paper
• Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice.

  2014cited by this paper
• Imaging , Diagnosis , Prognosis Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer

  2014cited by this paper
• Ipilimumab and whole brain radiation therapy for melanoma brain metastases

  2014cited by this paper
• Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade.

  2014cited by this paper
• Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy

  2014cited by this paper
• Radiation-enhanced cell migration/invasion process: a review.

  2014cited by this paper
• Genetic basis for clinical response to CTLA-4 blockade in melanoma.

  2014cited by this paper
• Radio‐responsive tumors exhibit greater intratumoral immune activity than nonresponsive tumors

  2014cited by this paper
• Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy

  2014cited by this paper
• Validation of heat shock protein 70 as a tumor-specific biomarker for monitoring the outcome of radiation therapy in tumor mouse models.

  2014cited by this paper
• Abscopal effect of radiation therapy: Interplay between radiation dose and p53 status

  2014cited by this paper
• Radiotherapy of Human Sarcoma Promotes an Intratumoral Immune Effector Signature

  2013cited by this paper
• Radiation therapy and immunotherapy: implications for a combined cancer treatment.

  2013cited by this paper
• Radiation-Induced Equilibrium Is a Balance between Tumor Cell Proliferation and T Cell–Mediated Killing

  2013cited by this paper
• Ipilimumab and radiation therapy for melanoma brain metastases

  2013cited by this paper
• The abscopal effect associated with a systemic anti-melanoma immune response.

  2013cited by this paper
• Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas.

  2013cited by this paper
• Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study.

  2013cited by this paper
• Concurrent Radiotherapy and Ipilimumab Immunotherapy for Patients with Melanoma

  2013cited by this paper
• Transient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy

  2013cited by this paper
• Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance.

  2013cited by this paper
• Controversies and challenges regarding the impact of radiation therapy on survival.

  2013cited by this paper
• CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer.

  2013cited by this paper
• Low-dose irradiation programs macrophage differentiation to an iNOS⁺/M1 phenotype that orchestrates effective T cell immunotherapy.

  2013cited by this paper
• Irradiation Promotes an M2 Macrophage Phenotype in Tumor Hypoxia

  2012cited by this paper
• Abscopal Regression of Antigen Disparate Tumors by Antigen Cascade After Systemic Tumor Vaccination in Combination with Local Tumor Radiation

  2012cited by this paper
• A systemic complete response of metastatic melanoma to local radiation and immunotherapy.

  2012cited by this paper
• Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer

  2012cited by this paper
• Immunologic correlates of the abscopal effect in a patient with melanoma.

  2012cited by this paper
• Synergy of Topical Toll-like Receptor 7 Agonist with Radiation and Low-Dose Cyclophosphamide in a Mouse Model of Cutaneous Breast Cancer

  2012cited by this paper
• Maximizing tumor immunity with fractionated radiation.

  2012cited by this paper
• In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study.

  2012cited by this paper
• Phase 1 Study of Stereotactic Body Radiotherapy and Interleukin-2—Tumor and Immunological Responses

  2012cited by this paper
• Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodies.

  2012cited by this paper
• Radiation as an immunological adjuvant: current evidence on dose and fractionation

  2012cited by this paper
• Blockade of TGF-beta signaling by the TGF β R-I kinase Inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma

  2011cited by this paper
• Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.

  2011cited by this paper
• TGFβ1 Inhibition Increases the Radiosensitivity of Breast Cancer Cells In Vitro and Promotes Tumor Control by Radiation In Vivo

  2011cited by this paper
• The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity.

  2011cited by this paper
• Intratumoral injection of interleukin‐2 augments the local and abscopal effects of radiotherapy in murine rectal cancer

  2011cited by this paper
• Decoding cell death signals in inflammation and immunity.

  2010cited by this paper
• Improved survival with ipilimumab in patients with metastatic melanoma.

  2010cited by this paper
• Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria

  2009cited by this paper
• Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment.

  2009cited by this paper
• Immunogenic and tolerogenic cell death

  2009cited by this paper
• Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 Antibody

  2009cited by this paper
• Radiation-Induced CXCL16 Release by Breast Cancer Cells Attracts Effector T Cells1

  2008cited by this paper
• Enhancement of Antitumor Radiation Efficacy and Consistent Induction of the Abscopal Effect in Mice by ECI301, an Active Variant of Macrophage Inflammatory Protein-1α

  2008cited by this paper
• Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

  2007cited by this paper
• Sensors of ionizing radiation effects on the immunological microenvironment of cancer

  2007cited by this paper
• Combination of direct intratumoral administration of dendritic cells and irradiation induces strong systemic antitumor effect mediated by GRP94/gp96 against squamous cell carcinoma in mice.

  2007cited by this paper
• Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis

  2007cited by this paper
• Local Radiation Therapy of B16 Melanoma Tumors Increases the Generation of Tumor Antigen-Specific Effector Cells That Traffic to the Tumor1

  2005cited by this paper
• Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

  2005cited by this paper
• Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer.

  2005cited by this paper
• Sublethal Irradiation of Human Tumor Cells Modulates Phenotype Resulting in Enhanced Killing by Cytotoxic T Lymphocytes

  2004cited by this paper
• Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated.

  2004cited by this paper
• T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell-cell contacts.

  2001cited by this paper
• Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients.

  2001cited by this paper
• The abscopal effect in malignant lymphoma and its relationship to lymphocyte circulation.

  1969cited by this paper

• Efficacy and Safety of Radiotherapy Combined with PD-1 Inhibitors and Targeted Therapy for Unresectable Hepatocellular Carcinoma: A Retrospective, Real-World Multicenter Study.

  2026cites this paper
• Recent progress in the treatment of locally advanced head and neck squamous cell carcinomas

  2025cites this paper
• Radioimmunotherapy for lung and head and neck cancers: A comparative review of clinical trial results and sequencing strategies.

  2025cites this paper
• Steroid-refractory Interstitial Lung Disease in Patients Receiving Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis

  2025cites this paper
• Abscopal Effects and Immunomodulation in Skin Cancer Therapy

  2025influential citation
• Efficacy of innovative systemic treatments in combination with radiotherapy for bone metastases: a GEMO (the European Study Group of Bone Metastases) state of the art

  2025cites this paper
• Stereotactic Ablative Radiotherapy for Delayed Retrobulbar Metastasis of Renal Cell Carcinoma: Therapeutic Outcomes and Practical Insights

  2025cites this paper
• Current status of neoadjuvant immunotherapy for the treatment of gastric cancer

  2024cites this paper
• A comprehensive overview of radiation therapy impacts of various cancer treatments and pivotal role in the immune system

  2024cites this paper
• TLR3 activation enhances abscopal effect of radiotherapy in HCC by promoting tumor ferroptosis

  2024cites this paper
• The potential role of precision medicine to alleviate racial disparities in prostate, bladder and renal urological cancer care

  2024cites this paper
• Bedeutung der Dosimetrie aus Sicht des Nuklearmediziners

  2023cites this paper
• Non-cellular immunotherapies in pediatric central nervous system tumors

  2023cites this paper
• Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma—randomized phase 2 trial ARION UCGI 33/PRODIGE 67: the study protocol

  2023cites this paper
• Effect of external beam radiation therapy versus transcatheter arterial chemoembolization for non-diffuse hepatocellular carcinoma (≥ 5 cm): a multicenter experience over a ten-year period

  2023cites this paper
• Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma

  2023cites this paper
• Implications of the Organ-Specific Immune Environment for Immune Priming Effect of Radiotherapy in Metastatic Setting

  2023cites this paper
• Impact of radiation therapy on healthy tissues.

  2023cites this paper
• PD-1 inhibitors plus anti-angiogenic therapy with or without intensity-modulated radiotherapy for advanced hepatocellular carcinoma: A propensity score matching study

  2022cites this paper
• Assessing toxicities of curative radiotherapy combined with concomitant non anti-cancer drugs: A sub-analysis of the prospective epidemiological RIT trial.

  2022cites this paper
• Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial.

  2022cites this paper
• Overcoming Immunotherapy Resistance With Radiation Therapy and Dual Immune Checkpoint Blockade

  2022cites this paper
• Survival in Patients With Metastatic Prostate Cancer Undergoing Radiotherapy: The Importance of Prostate-Specific Antigen-Based Stratification

  2021cites this paper
• Tumor-infiltrating lymphocytes predict improved overall survival after post-mastectomy radiotherapy: a study of the randomized DBCG82bc cohort

  2021cites this paper
• PD-1 iNhibitor and chemotherapy with concurrent IRradiation at VAried tumor sites in advanced Non-small cell lung cAncer: the Prospective Randomized Phase 3 NIRVANA-Lung Trial.

  2021cites this paper
• Management of stage IIIA NSCLC: the role of radiotherapy—a narrative review

  2021cites this paper
• Thinking Outside the Field: Two Cases of RT+ICI Synergy in Melanoma

  2021cites this paper
• Stereotactic body radiotherapy and checkpoint inhibitor for locally recurrent unresectable nasopharyngeal carcinoma

  2021cites this paper
• A Biomathematical Model of Tumor Response to Radioimmunotherapy With αPDL1 and αCTLA4

  2021cites this paper
• Could Protons Promote Tumor Control by Avoiding Lymphopenia?

  2021cites this paper
• Apport de la TEP-TDM au 18F-FDG chez des patients avec cancer bronchique non à petites cellules ou mélanome métastatique traités par immunothérapie

  2021cites this paper
• Immune Response: A Missed Opportunity Between Vitamin D and Radiotherapy

  2021cites this paper
• Sequence of αPD-1 relative to local tumor irradiation determines the induction of abscopal antitumor immune responses

  2021cites this paper
• Overview of checkpoint inhibitor pneumonitis: incidence and associated risk factors

  2021cites this paper
• Methodological Development of Combination Drug and Radiotherapy in Basic and Clinical Research

  2020cites this paper
• Abscopal effect of local irradiation treatment for thymoma: a case report.

  2020cites this paper
• A review of radiation induced abscopal effect: combining radiotherapy and immunotherapy to treat the untreated distant metastatic tumours

  2020cites this paper
• Irradiation de la maladie primitive des cancers de la prostate avec métastases synchrones

  2020cites this paper
• Pure abscopal effect of radiotherapy in a salivary gland carcinoma: Case report, literature review, and a search for new approaches.

  2020cites this paper
• Radiotherapy-Mediated Immunomodulation and Anti-Tumor Abscopal Effect Combining Immune Checkpoint Blockade

  2020cites this paper
• The mechanism and risk factors for immune checkpoint inhibitor pneumonitis in non-small cell lung cancer patients

  2020cites this paper
• Targeting Oligometastasis with Stereotactic Ablative Radiation Therapy or Surgery in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review of Prospective Clinical Trials.

  2020cites this paper
• [Treatment of primary disease for synchronous metastatic prostate cancer].

  2020cites this paper
• Dose escalation phase 1 study of radiotherapy in combination with anti-cytotoxic-T-lymphocyte-associated antigen 4 monoclonal antibody ipilimumab in patients with metastatic melanoma

  2020cites this paper
• [Role of immunotherapy in locally advanced non-small cell lung cancer].

  2020cites this paper
• The role of radiation therapy and systemic therapies in elderly with breast cancer

  2020influential citation
• Abscopal effect of radiation therapy after nivolumab monotherapy in a patient with oral mucosal melanoma: A case report.

  2020cites this paper
• On the way of the new strategies aimed to improve the efficacy of PD-1/PD-L1 immune checkpoint blocking mAbs in small cell lung cancer

  2020influential citation
• Abscopal effect in radioimmunotherapy.

  2020cites this paper
• The potential combinational immunotherapiesfor treatment of hepatocellular carcinoma

  2019cites this paper
• In situ vaccination: Harvesting low hanging fruit on the cancer immunotherapy tree.

  2019cites this paper
• Administration of Dendritic Cells and Anti-PD-1 Antibody Converts X-ray Irradiated Tumors Into Effective In situ Vaccines.

  2019cites this paper
• Rationale for combination of radiation therapy and immune checkpoint blockers to improve cancer treatment

  2019cites this paper
• Combination of Immunotherapy and Brain Radiotherapy in Metastatic Melanoma: A Retrospective Analysis

  2019cites this paper
• [Treatment of patients with brain metastases from a melanoma].

  2019cites this paper
• Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapy

  2019cites this paper
• [Therapeutic options for oligoprogressive non-small cell lung cancer].

  2019cites this paper
• Effects of irradiated cell conditioned medium on the response of human lung cancer cells to anticancer treatment in vitro

  2019cites this paper
• Cancer de l’œsophage : radio-chimiothérapie exclusive ou préopératoire ?

  2019cites this paper
• Possible Abscopal Effect Observed in Frontal Meningioma After Localized IMRT on Posterior Meningioma Resection Cavity Without Adjuvant Immunotherapy

  2019cites this paper
• Cytoreductive treatment strategies for de novo metastatic prostate cancer

  2019cites this paper
• IDO inhibitor synergized with radiotherapy to delay tumor growth by reversing T cell exhaustion.

  2019cites this paper
• Relationship between immune-related adverse events and the long-term outcomes in recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab.

  2019cites this paper
• [Stereotactic body radiotherapy: Passing fad or revolution?]

  2019cites this paper
• Radiothérapie et immunothérapie : nouveau standard, nouvelles options

  2019cites this paper
• Radiobiology of brachytherapy: The historical view based on linear quadratic model and perspectives for optimization.

  2018cites this paper
• Vaccine Therapy in Pancreatic Cancer

  2018cites this paper
• Radiothérapie et immunothérapie

  2018cites this paper
• How to Increase the Efficacy of Immunotherapy in NSCLC and HNSCC: Role of Radiation Therapy, Chemotherapy, and Other Strategies

  2018cites this paper
• Previous Radiotherapy Increases the Efficacy of IL-2 in Malignant Pleural Effusion: Potential Evidence of a Radio-Memory Effect?

  2018cites this paper
• Radiotherapy and immune response: the systemic effects of a local treatment

  2018cites this paper
• Combination Immunotherapy Development in Melanoma.

  2018cites this paper
• Inflammation Flare and Radiation Necrosis Around a Stereotactic Radiotherapy-Pretreated Brain Metastasis Site After Nivolumab Treatment.

  2018cites this paper
• Harnessing drug/radiation interaction through daily routine practice: Leverage medical and methodological point of view (MORSE 02-17 study).

  2018cites this paper
• Stereotactic body radiation therapy and thymosin alpha-1-induced anti-tumor effects in heavily pretreated, metastatic esophageal squamous cell carcinoma patients

  2018cites this paper
• "Radiobiology of Proton Therapy": Results of an international expert workshop.

  2018cites this paper
• Leukocytosis, prognosis biomarker in locally advanced head and neck cancer patients after chemoradiotherapy

  2018cites this paper
• The potentially conflicting cell autonomous and cell non‐autonomous functions of autophagy in mediating tumor response to cancer therapy

  2018cites this paper
• Oncolytic Virus Combination Therapy: Killing One Bird with Two Stones.

  2018cites this paper
• Radiotherapy for Tracheal-Bronchial Cystic Adenoid Carcinomas.

  2018cites this paper
• Metformin for non-small cell lung cancer patients: Opportunities and pitfalls.

  2018cites this paper
• Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy

  2018cites this paper
• Hypothesis: can the abscopal effect explain the impact of adjuvant radiotherapy on breast cancer mortality?

  2018cites this paper
• The effects of radiotherapy on the survival of patients with unresectable non-small cell lung cancer

  2018influential citation
• Abscopal effects of radiotherapy and combined mRNA-based immunotherapy in a syngeneic, OVA-expressing thymoma mouse model

  2018cites this paper
• An Exploratory Study of Radiation Dermatitis in Breast Cancer Patients.

  2018cites this paper
• Immunological effect of local ablation combined with immunotherapy on solid malignancies

  2017cites this paper
• Neutrophils, a candidate biomarker and target for radiation therapy?

  2017influential citation
• Toward Personalized Dosimetry with 32P Microparticle Therapy for Advanced Pancreatic Cancer.

  2017cites this paper
• Early clinical outcome of coverage probability based treatment planning for simultaneous integrated boost of nodes in locally advanced cervical cancer

  2017cites this paper
• Current and Emerging Therapies in Pancreatic Cancer

  2017cites this paper
• Abscopal Effect of Local Irradiation Treatment for Diffuse Large B-cell Lymphoma.

  2017cites this paper
• Oncolytic peptide LTX-315 induces an immune-mediated abscopal effect in a rat sarcoma model

  2017cites this paper
• The Current Role of Whole Brain Radiation Therapy in Non–Small Cell Lung Cancer Patients

  2017cites this paper
• Beyond Just Androgen Deprivation Therapy: Novel Therapies Combined With Radiation.

  2017cites this paper
• Clinical relevance of tumor infiltrating lymphocytes, PD-L1 expression and correlation with HPV/p16 in head and neck cancer treated with bio- or chemo-radiotherapy

  2017cites this paper
• [Immunotherapy and radiotherapy].

  2017cites this paper
• Leukocytosis and neutrophilia predicts outcome in anal cancer.

  2017cites this paper
• Prognostic impact of leukocyte counts before and during radiotherapy for oropharyngeal cancer

  2017cites this paper
• Candidate immune biomarkers for radioimmunotherapy.

  2017cites this paper